RPB-supported researchers have discovered a biological marker for wet age-related macular degeneration (AMD) that shows strong potential as a means for both early detection and preventive treatment.
"This is a major paradigm shift in macular degeneration research," said Jayakrishna Ambati, M.D., a professor of physiology, professor and vice-chair of ophthalmology and visual sciences, RPB awardee, and the Dr. E. Vernon and Eloise C. Smith Endowed Chair in Macular Degeneration at the UK College of Medicine. "We have for the first time found a unique molecular signature for the disease. This brings us closer than we have ever been to developing a clinical diagnostic tool to discover and treat the disease early, before vision is lost."
June 15, 2009